Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 37.53
Key Takeaways
Risk factor
Meaningful price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, Chinese anti-inflammatory, pediatric, gynecology, hepatobiliary, and specialty drugs. The company was founded in 1997 and is headquartered in Xi'an, China.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, over
Data is available to registered users only
Buy
Sell